HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer cell specific gene delivery by laminin-derived peptide AG73-labeled liposomes.

Abstract
We developed laminin-derived AG73 peptide labeled liposomes for cancer specific gene therapy. AG73 peptide is well known as a ligand for syndecan-2 which is highly expressed in various cancer cells. Liposomes labeled with AG73 showed high efficient transfection efficiency in syndecan-2 overexpressing cells, and found that AG73 could be a superior molecule in the development of non-viral vector using liposomes for the gene delivery to syndecan-2 overexpressing cancer cells.
AuthorsHiroshi Iijima, Yoichi Negishi, Daiki Omata, Motoyoshi Nomizu, Yukihiko Aramaki
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 20 Issue 15 Pg. 4712-4 (Aug 01 2010) ISSN: 1464-3405 [Electronic] England
PMID20615691 (Publication Type: Journal Article)
CopyrightCopyright 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Laminin
  • Liposomes
  • Peptides
  • Syndecan-2
Topics
  • Amino Acid Sequence
  • Antineoplastic Agents (administration & dosage, chemistry)
  • Cell Line
  • Humans
  • Laminin (chemistry)
  • Liposomes (chemistry)
  • Molecular Sequence Data
  • Neoplasms (therapy)
  • Peptides (administration & dosage, chemistry)
  • Syndecan-2 (antagonists & inhibitors, metabolism)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: